“…evaluating palbociclib (CDK4/6) treatment outcome …”
 

https://www.biospace.com/article/rel...cer-treatment/

https://clincancerres.aacrjournals.o.../2131.abstract

https://www.nature.com/articles/s41598-020-61416-1

I need to be more rigorous in monitoring/reading research, these articles were published in Jannuary/2020. I believe they are filing for FDA approval of Divitum.

Nguyen